These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24718045)

  • 21. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.
    Campbell JC; Jeyamohan SB; De La Cruz P; Chen N; Shin D; Pilitsis JG
    Behav Brain Res; 2014 Dec; 275():114-9. PubMed ID: 25205367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 6-hydroxydopamine model of Parkinson's disease.
    Simola N; Morelli M; Carta AR
    Neurotox Res; 2007 Apr; 11(3-4):151-67. PubMed ID: 17449457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model.
    Tentillier N; Etzerodt A; Olesen MN; Rizalar FS; Jacobsen J; Bender D; Moestrup SK; Romero-Ramos M
    J Neurosci; 2016 Sep; 36(36):9375-90. PubMed ID: 27605613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
    Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.
    Gregório ML; Wietzikoski EC; Ferro MM; Silveira JL; Vital MA; Da Cunha C
    Neurotox Res; 2009 May; 15(4):359-66. PubMed ID: 19384569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease.
    Ciucci MR; Schaser AJ; Russell JA
    Behav Brain Res; 2013 Sep; 252():239-45. PubMed ID: 23756136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
    Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
    Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Episodic hypoxia induces long-term facilitation of neural drive to tongue protrudor and retractor muscles.
    Fuller DD
    J Appl Physiol (1985); 2005 May; 98(5):1761-7. PubMed ID: 15640385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early postnatal chronic intermittent hypoxia modifies hypoxic respiratory responses and long-term phrenic facilitation in adult rats.
    Reeves SR; Mitchell GS; Gozal D
    Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1664-71. PubMed ID: 16455761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective loss of high-frequency oscillations in phrenic and hypoglossal activity in the decerebrate rat during gasping.
    Marchenko V; Rogers RF
    Am J Physiol Regul Integr Comp Physiol; 2006 Nov; 291(5):R1414-29. PubMed ID: 16825420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
    Gronlier E; Volle J; Coizet V; Paccard A; Habermacher C; Roche Y; Roucard C; Duveau V; David O
    Neurobiol Dis; 2023 Sep; 185():106266. PubMed ID: 37604316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigral 6-hydroxydopamine lesion impairs performance in a lateralised choice reaction time task--impact of training and task parameters.
    Lindgren HS; Klein A; Dunnett SB
    Behav Brain Res; 2014 Jun; 266():207-15. PubMed ID: 24613237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory-related hypoglossal nerve activity: influence of anesthetics.
    Hwang JC; St John WM; Bartlett D
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Sep; 55(3):785-92. PubMed ID: 6629915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease.
    Walsh S; Gavin A; Wyatt S; O'Connor C; Keeshan K; Nolan YM; O'Keeffe GW; Sullivan AM
    Int J Neurosci; 2015 Jan; 125(1):70-7. PubMed ID: 24628580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.